• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/28/23 1:43:37 PM ET
    $SEV
    $SMR
    $SOLO
    $SPRC
    Auto Manufacturing
    Industrials
    Metal Fabrications
    Industrials
    Get the next $SEV alert in real time by email

     

    During Tuesday, 95 stocks hit new 52-week lows.

    Areas of Interest About Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Wipro (NYSE:WIT).
    • Kiromic BioPharma (NASDAQ:KRBP) was the smallest firm by market cap to set a new 52-week low.
    • Monopar Therapeutics (NASDAQ:MNPR)'s stock came under the most pressure, trading down 50.09% to reach a new 52-week low.
    • Athira Pharma (NASDAQ:ATHA) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Tuesday:

    • Wipro (NYSE:WIT) shares made a new 52-week low of $4.35 on Tuesday. The stock was down 1.58% for the day.
    • Plug Power (NASDAQ:PLUG) stock drifted down 2.38% on Tuesday morning to hit a new 52-week low of $10.37.
    • Frontier Communications (NASDAQ:FYBR) shares set a new yearly low of $20.77 this morning. The stock was down 3.07% on the session.
    • Harmony Biosciences (NASDAQ:HRMY) shares made a new 52-week low of $29.86 on Tuesday. The stock was down 20.29% for the day.
    • Globalstar (AMEX:GSAT) stock hit a yearly low of $0.97. The stock was up 0.2% for the day.
    • AMTD Digital (NYSE:HKD) stock broke to a new 52-week low of $6.71 on Tuesday. Shares of the company traded down 0.73%.
    • PROCEPT BioRobotics (NASDAQ:PRCT) stock hit $28.23 on Tuesday morning, setting a new 52-week low for a change of down 0.49%.
    • Sterling Check (NASDAQ:STER) shares reached a new 52-week low of $10.57 on Tuesday morning, moving down 3.61%.
    • Nexters (NASDAQ:GDEV) stock hit a new 52-week low of $3.10. The stock was up 13.21% on the session.
    • Xometry (NASDAQ:XMTR) stock dropped to a yearly low on Tuesday of $13.98. Shares traded down 2.4%.
    • Allego (NYSE:ALLG) stock hit a new 52-week low of $2.19. The stock was down 1.35% on the session.
    • NuScale Power (NYSE:SMR) shares made a new 52-week low of $8.10 on Tuesday. The stock was down 2.13% for the day.
    • iHeartMedia (NASDAQ:IHRT) stock dropped to a yearly low on Tuesday of $3.70. Shares traded down 8.16%.
    • Editas Medicine (NASDAQ:EDIT) shares hit a yearly low of $7.26. The stock was down 1.81% on the session.
    • India Fund (NYSE:IFN) stock achieved a new 52-week low on Tuesday morning, hitting $14.48 and moving down 0.68%.
    • American Software (NASDAQ:AMSWA) stock set a new 52-week low of $12.00 on Tuesday, moving down 1.31%.
    • Eaton Vance Tax-Managed (NYSE:ETB) stock hit a yearly low of $12.70. The stock was down 0.47% for the day.
    • Tremor Intl (NASDAQ:TRMR) stock broke to a new 52-week low of $5.09 on Tuesday. Shares of the company traded down 1.71%.
    • Hyliion Holdings (NYSE:HYLN) shares made a new 52-week low of $1.98 on Tuesday. The stock was down 4.57% for the day.
    • Aura Biosciences (NASDAQ:AURA) stock achieved a new 52-week low on Tuesday morning, hitting $8.63 and moving up 3.37%.
    • PetMed Express (NASDAQ:PETS) shares were up 1.19% for the day, having made a 52-week low of $15.83.
    • Microvast Holdings (NASDAQ:MVST) stock broke to a new 52-week low of $1.06 on Tuesday. Shares of the company traded down 2.75%.
    • Inogen (NASDAQ:INGN) stock broke to a new 52-week low of $12.09 on Tuesday. Shares of the company traded down 1.7%.
    • Ouster (NYSE:OUST) stock set a new 52-week low of $0.70 on Tuesday, moving down 1.5%.
    • Lilium (NASDAQ:LILM) shares moved down 0.33% on Tuesday to hit a new 52-week low of $0.64, drifting down 0.33%.
    • YS Biopharma Co (NASDAQ:YS) stock hit $2.60 on Tuesday morning, setting a new 52-week low for a change of down 10.6%.
    • Aeva Technologies (NYSE:AEVA) stock set a new 52-week low of $1.09 on Tuesday, moving down 2.65%.
    • Near Intelligence (NASDAQ:NIR) stock hit $3.75 on Tuesday morning, setting a new 52-week low for a change of down 21.57%.
    • Inovio Pharmaceuticals (NASDAQ:INO) shares moved down 6.07% on Tuesday to hit a new 52-week low of $0.80, drifting down 6.07%.
    • Cloopen Group Holding (NYSE:RAAS) shares hit a yearly low of $1.34. The stock was down 4.51% on the session.
    • USCB Financial Holdings (NASDAQ:USCB) stock hit $10.70 on Tuesday morning, setting a new 52-week low for a change of down 1.1%.
    • Cohen & Steers Select (NYSE:PSF) shares moved down 0.34% on Tuesday to hit a new 52-week low of $17.28, drifting down 0.34%.
    • Heron Therapeutics (NASDAQ:HRTX) stock hit a new 52-week low of $1.68. The stock was down 2.02% on the session.
    • Invesco High Income 2023 (NYSE:IHIT) shares moved up 0.26% on Tuesday to hit a new 52-week low of $7.55, drifting up 0.26%.
    • Aadi Bioscience (NASDAQ:AADI) stock broke to a new 52-week low of $6.98 on Tuesday. Shares of the company traded down 3.03%.
    • Meta Materials (NASDAQ:MMAT) stock dropped to a yearly low on Tuesday of $0.44. Shares traded down 3.78%.
    • C4 Therapeutics (NASDAQ:CCCC) shares moved down 1.3% on Tuesday to hit a new 52-week low of $3.32, drifting down 1.3%.
    • Moolec Science (NASDAQ:MLEC) shares made a new 52-week low of $4.30 on Tuesday. The stock was down 0.23% for the day.
    • Edgio (NASDAQ:EGIO) shares hit a yearly low of $0.70. The stock was up 1.26% on the session.
    • Investar Holding (NASDAQ:ISTR) shares reached a new 52-week low of $14.76 on Tuesday morning, moving down 1.39%.
    • Bright Health Gr (NYSE:BHG) stock broke to a new 52-week low of $0.21 on Tuesday. Shares of the company traded down 0.58%.
    • Virgin Orbit Holdings (NASDAQ:VORB) stock dropped to a yearly low on Tuesday of $0.37. Shares traded down 23.48%.
    • Babylon Holdings (NYSE:BBLN) stock hit $5.35 on Tuesday morning, setting a new 52-week low for a change of down 7.12%.
    • Groupon (NASDAQ:GRPN) stock hit $3.58 on Tuesday morning, setting a new 52-week low for a change of down 0.69%.
    • Arrival (NASDAQ:ARVL) stock set a new 52-week low of $0.14 on Tuesday, moving down 6.44%.
    • Yellow (NASDAQ:YELL) stock hit a new 52-week low of $1.91. The stock was down 3.04% on the session.
    • RumbleON (NASDAQ:RMBL) stock hit $5.90 on Tuesday morning, setting a new 52-week low for a change of down 8.47%.
    • Alpine 4 Holdings (NASDAQ:ALPP) shares reached a new 52-week low of $0.45 on Tuesday morning, moving up 0.2%.
    • Athira Pharma (NASDAQ:ATHA) shares set a new yearly low of $2.31 this morning. The stock was 0.0% (flat) on the session.
    • Village Farms Intl (NASDAQ:VFF) shares moved down 0.78% on Tuesday to hit a new 52-week low of $0.80, drifting down 0.78%.
    • Kore Group Holdings (NYSE:KORE) shares were down 12.0% for the day, having made a 52-week low of $1.07.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $2.14 on Tuesday morning, moving up 2.02%.
    • KULR Tech Gr (AMEX:KULR) shares set a new 52-week low of $0.66. The stock traded down 9.7%.
    • Lee Enterprises (NASDAQ:LEE) stock dropped to a yearly low on Tuesday of $12.43. Shares traded down 0.45%.
    • JOANN (NASDAQ:JOAN) shares were down 3.31% for the day, having made a 52-week low of $1.74.
    • Dave (NASDAQ:DAVE) stock broke to a new 52-week low of $5.82 on Tuesday. Shares of the company traded down 2.5%.
    • Inspirato (NASDAQ:ISPO) shares hit a yearly low of $0.86. The stock was up 1.59% on the session.
    • Clearside Biomedical (NASDAQ:CLSD) stock hit $0.92 on Tuesday morning, setting a new 52-week low for a change of down 1.58%.
    • Electrameccanica Vehicles (NASDAQ:SOLO) shares reached a new 52-week low of $0.46 on Tuesday morning, moving down 5.3%.
    • FreightCar America (NASDAQ:RAIL) stock hit $2.94 on Tuesday morning, setting a new 52-week low for a change of down 1.73%.
    • Advanced Emissions Solns (NASDAQ:ADES) stock broke to a new 52-week low of $1.70 on Tuesday. Shares of the company traded up 0.54%.
    • VirTra (NASDAQ:VTSI) shares set a new yearly low of $3.70 this morning. The stock was up 0.02% on the session.
    • Rubicon Technologies (NYSE:RBT) stock dropped to a yearly low on Tuesday of $0.64. Shares traded down 11.41%.
    • Exela Technologies (NASDAQ:XELA) stock drifted down 3.37% on Tuesday morning to hit a new 52-week low of $0.03.
    • Sono Group (NASDAQ:SEV) shares set a new yearly low of $0.33 this morning. The stock was down 4.38% on the session.
    • Fusion Fuel Green (NASDAQ:HTOO) stock hit a new 52-week low of $2.24. The stock was down 2.11% on the session.
    • Dogness (Intl) (NASDAQ:DOGZ) shares hit a yearly low of $0.73. The stock was down 3.93% on the session.
    • Evaxion Biotech (NASDAQ:EVAX) shares made a new 52-week low of $0.92 on Tuesday. The stock was down 13.22% for the day.
    • Unity Biotechnology (NASDAQ:UBX) stock drifted down 10.77% on Tuesday morning to hit a new 52-week low of $1.71.
    • SAB Biotherapeutics (NASDAQ:SABS) shares made a new 52-week low of $0.44 on Tuesday. The stock was down 1.88% for the day.
    • Monopar Therapeutics (NASDAQ:MNPR) stock set a new 52-week low of $1.35 on Tuesday, moving down 50.09%.
    • Aceragen (NASDAQ:ACGN) stock dropped to a yearly low on Tuesday of $2.14. Shares traded down 3.3%.
    • Better Therapeutics (NASDAQ:BTTX) stock hit a yearly low of $0.75. The stock was down 6.59% for the day.
    • Future FinTech Gr (NASDAQ:FTFT) stock hit a new 52-week low of $1.10. The stock was down 1.94% on the session.
    • Akari Therapeutics (NASDAQ:AKTX) shares made a new 52-week low of $0.21 on Tuesday. The stock was down 5.79% for the day.
    • Charah Solns (NYSE:CHRA) stock hit a new 52-week low of $3.25. The stock was down 4.4% on the session.
    • Forward Industries (NASDAQ:FORD) stock set a new 52-week low of $0.97 on Tuesday, moving down 0.28%.
    • Conformis (NASDAQ:CFMS) shares reached a new 52-week low of $1.09 on Tuesday morning, moving down 3.51%.
    • Cryptyde (NASDAQ:TYDE) stock hit a yearly low of $0.08. The stock was down 6.95% for the day.
    • WaveDancer (NASDAQ:WAVD) shares set a new 52-week low of $0.25. The stock traded down 1.63%.
    • Clearmind Medicine (NASDAQ:CMND) stock achieved a new 52-week low on Tuesday morning, hitting $1.61 and moving down 18.29%.
    • PolarityTE (NASDAQ:PTE) stock hit $0.58 on Tuesday morning, setting a new 52-week low for a change of down 7.18%.
    • Secoo Holding (NASDAQ:SECO) shares were down 2.66% for the day, having made a 52-week low of $0.53.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) stock hit a yearly low of $1.46. The stock was down 4.27% for the day.
    • IT Tech Packaging (AMEX:ITP) shares moved down 4.09% on Tuesday to hit a new 52-week low of $0.37, drifting down 4.09%.
    • Agrify (NASDAQ:AGFY) shares fell to $0.15 on Tuesday, setting a new 52-week low with a shift of up 5.0%.
    • Vyant Bio (NASDAQ:VYNT) shares set a new 52-week low of $0.59. The stock traded down 6.25%.
    • Assure Hldgs (NASDAQ:IONM) shares fell to $3.02 on Tuesday, setting a new 52-week low with a shift of down 8.11%.
    • SciSparc (NASDAQ:SPRC) shares hit a yearly low of $0.47. The stock was down 6.86% on the session.
    • Kiromic BioPharma (NASDAQ:KRBP) shares reached a new 52-week low of $3.70 on Tuesday morning, moving down 3.08%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $SEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEV
    $SMR
    $SOLO
    $SPRC

    CompanyDatePrice TargetRatingAnalyst
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    PROCEPT BioRobotics Corporation
    $PRCT
    2/26/2026Outperform → Perform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    2/26/2026$20.00Neutral → Underperform
    BofA Securities
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/23/2026Buy → Hold
    Deutsche Bank
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/23/2026Buy → Hold
    Truist
    Evaxion A/S
    $EVAX
    2/19/2026$10.00Buy
    Maxim Group
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    Harmony Biosciences Holdings Inc.
    $HRMY
    2/11/2026$46.00Neutral
    UBS
    More analyst ratings

    $SEV
    $SMR
    $SOLO
    $SPRC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Pittman Robert W converted options into 256,667 shares, covered exercise/tax liability with 160,012 shares and returned $464,909 worth of shares to the company (146,659 units at $3.17), decreasing direct ownership by 0.81% to 6,182,469 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    2/27/26 8:00:06 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    CFO Mcguinness Michael B converted options into 29,167 shares, covered exercise/tax liability with 29,780 shares and returned $45,258 worth of shares to the company (14,277 units at $3.17), decreasing direct ownership by 2% to 757,861 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    2/27/26 8:00:04 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    President and COO Bressler Richard J covered exercise/tax liability with 160,012 shares, returned $464,909 worth of shares to the company (146,659 units at $3.17) and converted options into 256,667 shares, decreasing direct ownership by 0.94% to 5,241,743 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    2/27/26 8:00:03 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    $SEV
    $SMR
    $SOLO
    $SPRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NuScale Power upgraded by Northland Capital with a new price target

    Northland Capital upgraded NuScale Power from Market Perform to Outperform and set a new price target of $21.00

    2/27/26 8:22:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    PROCEPT BioRobotics downgraded by Oppenheimer

    Oppenheimer downgraded PROCEPT BioRobotics from Outperform to Perform

    2/26/26 7:23:22 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    PROCEPT BioRobotics downgraded by BofA Securities with a new price target

    BofA Securities downgraded PROCEPT BioRobotics from Neutral to Underperform and set a new price target of $20.00

    2/26/26 7:11:50 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    SEC Filings

    View All

    SEC Form 6-K filed by Evaxion A/S

    6-K - Evaxion A/S (0001828253) (Filer)

    2/27/26 4:45:16 PM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form S-8 filed by Inogen Inc

    S-8 - Inogen Inc (0001294133) (Filer)

    2/27/26 4:33:26 PM ET
    $INGN
    Industrial Specialties
    Health Care

    SEC Form 10-K filed by Globalstar Inc.

    10-K - Globalstar, Inc. (0001366868) (Filer)

    2/27/26 4:27:30 PM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    $SEV
    $SMR
    $SOLO
    $SPRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, with summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on the Company's investor relations w

    2/27/26 4:25:00 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hoffmann David Henry bought $390,078 worth of shares (44,110 units at $8.84), increasing direct ownership by 0.40% to 11,017,249 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/26/26 4:26:31 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Director Hoffmann David Henry bought $314,784 worth of shares (36,400 units at $8.65), increasing direct ownership by 0.33% to 10,973,139 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/23/26 6:09:33 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Director Hoffmann David Henry bought $194,992 worth of shares (27,299 units at $7.14), increasing direct ownership by 0.25% to 10,936,739 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/18/26 5:17:23 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    $SEV
    $SMR
    $SOLO
    $SPRC
    Leadership Updates

    Live Leadership Updates

    View All

    Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Prafulla Gokhale, Ph.D., Director of the Experimental Therapeutics Core and the Lurie Family Imaging Center at Dana-Farber Cancer Institute, to its Scientific Advisory Board. "Dr. Gokhale's expertise in experimental therapeutics, RNA biology and translational oncology comes at a pivotal time as we advance AKTX-101 toward the clinic," commented Abizer Gaslightwala, President and CEO of Akari Therapeutics. "His proven track record to develop novel t

    2/26/26 9:10:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Olga Anczukow, Ph.D. to its Scientific Advisory Board (SAB). Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics commented, "Dr. Anczukow is a leading authority in RNA splicing and cancer biology, an area of growing importance for the development of next-generation therapeutics. Her scientific rigor, translational mindset, and experience advancing RNA-focused discoveries toward clinical relevance make her an outstandin

    2/23/26 8:50:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Plug Power Calls on Stockholders to Act Now and Vote in Favor of Proposals at January 29, 2026 Special Meeting

    SLINGERLANDS, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, encourages stockholders to vote their shares ahead of the Company's Special Meeting of Stockholders (the "Special Meeting") scheduled for January 29, 2026. The Special Meeting includes proposals that are critical to supporting the Company's ongoing operations, financial flexibility and long-term growth strategy. The Board of Directors urges stockholders of record as of December 12, 2025 (the "Record Date") to vote their shares in favor of all proposals presented at the Special Meeting. This Special Meeting follows the Company's

    1/27/26 2:14:23 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

    Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

    6/26/24 3:07:15 PM ET
    $ATHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    Financials

    Live finance-specific insights

    View All

    Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

    The Eaton Vance closed-end funds listed below released today the estimated sources of their February distributions (each a "Fund"). This press release is issued as required by the Funds' managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the February distribution. It is not determinative of the tax character of a Fund's distributions for

    2/27/26 4:00:00 PM ET
    $EOI
    $EOS
    $ETB
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Investment Bankers/Brokers/Service

    Globalstar Announces Fourth Quarter and Full Year 2025 Results

    Strong year-over-year growth demonstrates improved market position Increased full year 2025 revenue 9% to a record $273.0 million in line with guidance Launched two-way satellite IoT capabilities and completed the commercial rollout of the RM200M module, expanding Globalstar's addressable markets Progressed global expansion of ground infrastructure to support launch of next-generation constellation Diversified market approach with key collaborations in government and defense Globalstar, Inc. (NASDAQ:GSAT) ("Globalstar" or the "Company") today announced its financial results for the fourth quarter and year ended December 31, 2025. Globalstar reported full year revenue of $27

    2/27/26 8:15:00 AM ET
    $GSAT
    Telecommunications Equipment
    Consumer Discretionary

    Village Farms International to Report Q4 and Full Year 2025 Results on March 12, 2026

    VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) today announced it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms Fourth Quarter 2025 Conference Call Webcast or on the Company website at Village Farms - Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms Fourth Quarter 2025 Conference Call Registration to receive telephone dial-in information. The live question and a

    2/26/26 4:30:00 PM ET
    $VFF

    $SEV
    $SMR
    $SOLO
    $SPRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Frontier Communications Parent Inc.

    SC 13D/A - Frontier Communications Parent, Inc. (0000020520) (Subject)

    12/12/24 4:15:11 PM ET
    $FYBR
    Telecommunications Equipment
    Telecommunications